Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells

Breast Cancer Research and Treatment

Volumn 91, Issue 3, 2005, Pages 271-278

  Viehl, Carsten T ^a,b   Tanaka, Yoshiyuki ^a,c   Chen, Tingting ^a   Frey, Daniel M ^a,b   Tran, Andrew ^a   Fleming, Timothy P ^a   Eberlein, Timothy J ^a   Goedegebuure, Peter S ^a,d  

^a USA   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presenting cell; Breast cancer vaccine; Mammaglobin; Protein transduction; T cells; Tat fusion protein

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAMMAGLOBIN; TRANSACTIVATOR PROTEIN;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BREAST CANCER; CONFOCAL MICROSCOPY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, TAT; HUMANS; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; UTEROGLOBIN;

EID: 21244446692     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-0450-4     Document Type: Article

References (26)

1. S Paczesny H Ueno J Fay J Banchereau AK Palucka 2003 Dendritic cells as vectors for immunotherapy of cancer Semin Cancer Biol 13 439 447
2. D Ridgway 2003 The first 1000 dendritic cell vaccinees Cancer Invest 21 873 886
3. Y Tanaka SF Dowdy DC Linehan TJ Eberlein PS Goedegebuure 2003 Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells J Immunol 170 1291 1298
4. M Becker-Hapak SS McAllister SF Dowdy 2001 TAT-mediated protein transduction into mammalian cells Methods 24 247 256
5. SR Schwarze KA Hruska SF Dowdy 2000 Protein transduction: unrestricted delivery into all cells Trends Cell Biol 10 290 295
6. JS Wadia SF Dowdy 2002 Protein transduction technology Curr Opin Biotechnol 13 52 56
7. H Nagahara AM Vocero-Akbani EL Snyder A Ho DG Latham NA Lissy M Becker-Hapak SA Ezhevsky SF Dowdy 1998 Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration Nat Med 4 1449 1452
8. AD Frankel CO Pabo 1988 Cellular uptake of the tat protein from human immunodeficiency virus Cell 55 1189 1193
9. SR Schwarze A Ho A Vocero-Akbani SF Dowdy 1999 In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1569 1572
10. DT Kim DJ Mitchell DG Brockstedt L Fong GP Nolan CG Fathman EG Engleman JB Rothbard 1997 Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide J Immunol 159 1666 1668
11. N Shibagaki MC Udey 2003 Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma Eur J Immunol 33 850 860
12. J Lu Y Higashimoto E Appella E Celis 2004 Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses J Immunol 172 4575 4582
13. HY Wang T Fu G Wang G Zeng DM Perry-Lalley JC Yang NP Restifo P Hwu RF Wang 2002 Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells J Clin Invest 109 1463 1470
14. N Shibagaki MC Udey 2002 Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity J Immunol 168 2393 2401
15. PS Goedegebuure MA Watson CT Viehl TP Fleming 2004 Mammaglobin-based strategies for treatment of breast cancer Curr Cancer Drug Targets 4 531 542
16. Y Tanaka KD Amos TP Fleming TJ Eberlein PS Goedegebuure 2003 Mammaglobin-A is a tumor-associated antigen in human breast carcinoma Surgery 133 74 80
17. A Ribas LH Butterfield JA Glaspy JS Economou 2003 Current developments in cancer vaccines and cellular immunotherapy J Clin Oncol 21 2415 2432
18. DM Pardoll SL Topalian 1998 The role of CD4+ T cell responses in antitumor immunity Curr Opin Immunol 10 588 594
19. RL Giuntoli 2nd J Lu H Kobayashi R Kennedy E Celis 2002 Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function Clin Cancer Res 8 922 931
20. RF Wang HY Wang 2002 Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells Nat Biotechnol 20 149 154
21. J Lu PJ Wettstein Y Higashimoto E Appella E Celis 2001 TAP-independent presentation of CTL epitopes by Trojan antigens J Immunol 166 7063 7071
22. MA Watson TP Fleming 1996 Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer Cancer Res 56 860 865
23. MA Watson S Dintzis CM Darrow LE Voss J DiPersio R Jensen TP Fleming 1999 Mammaglobin expression in primary, metastatic, and occult breast cancer Cancer Res 59 3028 3031
24. A Jaramillo K Majumder PP Manna TP Fleming G Doherty JF Dipersio T Mohanakumar 2002 Identification of HLA-A3- restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer Int J Cancer 102 499 506
25. PP Manna A Jaramillo K Majumder LG Campbell TP Fleming JR Dietz JF Dipersio T Mohanakumar 2003 Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells Breast Cancer Res Treat 79 133 136
26. K Narayanan A Jaramillo ND Benshoff LG Campbell TP Fleming JR Dietz T Mohanakumar 2004 Response of established human breast tumors to vaccination with mammaglobin-A cDNA J Natl Cancer Inst 96 1388 1396